GenSight Biologics confirms the success of its IPO by exercising 88.9% of the over-allotment option
http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=12&cntnt01returnid=37
Pixium Vision announces CE market approval of IRIS®II, its first bionic vision system
http://www.pixium-vision.com/file_bdd/dynamic_content/file_pdf_pdf_en/1469398551_Pixium_Vision_CEmarkIRISII-ENG-FINAL-FINAL-CLEAN.pdf
Gecko Biomedical raises €22.5 million led by Sofinnova partners
Gecko Biomedical raises €22.5 million led by Sofinnova Partners
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy
http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=8&cntnt01returnid=37
Pixium Vision implants IRIS® II,first epi-retinal implant with 150 electrodes
http://www.pixium-vision.com/file_bdd/dynamic_content/file_pdf_pdf_en/1456851776_PixiumVision-IRISIIActivation-ENGFinal.pdf